LEGN — Legend Biotech Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1801198 ·
Last close
$16.11
Market Cap
$3.13B
52W High
$37.50
52W Low
$15.75
ADV30
2,451,722
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 359,500,000 | 211,900,000 | 46,800,000 | 51,700,000 | 1,681,400,000 | 460,700,000 | 408,700,000 |
| Jun 2026 | 387,500,000 | 250,100,000 | 57,700,000 | 33,200,000 | 1,750,900,000 | 672,900,000 | 521,300,000 |
| Mar 2026 | 305,100,000 | 129,200,000 | -49,800,000 | -54,300,000 | 1,596,700,000 | 646,400,000 | 629,000,000 |
| Dec 2025 | 306,377,000 | 182,918,000 | -20,602,000 | -30,815,000 | 1,733,700,000 | 901,900,000 | 731,600,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-89,400,000
Investing CF
$330,500,000
Financing CF
$166,500,000
CapEx
$-32,400,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.50
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,979,600,000
Inventory
$41,500,000
Receivables
$198,000,000
ST Investments
$291,700,000
EBIT TTM
$-33,855,000
Pretax Income TTM
$-56,272,000
Interest Exp TTM
$22,417,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,271,399,936
EBITDA
$-41,600,000
Free Cash Flow
$27,193,000
Enterprise Value
$2,925,462,784
Total Cash
$964,600,000
Total Debt
$278,200,000
Shares Out
194,488,413
Trailing EPS
$-0.50
Book Value
$6.35
ROE
-8.1%
ROA
-1.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,028,900,000 | -136,500,000 | -296,800,000 | 1,733,700,000 | 731,600,000 | 1,002,100,000 | -100,200,000 |
| Dec 2024 | 627,300,000 | -309,500,000 | -177,000,000 | 1,670,200,000 | 629,600,000 | 1,040,600,000 | -144,000,000 |
| Dec 2023 | 285,100,000 | -528,100,000 | -518,300,000 | 1,848,609,000 | 597,238,000 | 1,251,371,000 | -393,300,000 |
| Dec 2022 | 117,005,000 | -455,620,000 | -446,349,000 | 1,330,963,000 | 586,651,000 | 744,312,000 | -201,281,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.05
Max Pain — expiry 2026-12-18
max pain strike: $22.50 · spot: $16.25 · call oi: 3,940 · put oi: 4,147
Expected Move to 2026-12-18:
±$2.97
(18.31%) —
implied range
$13.28 –
$19.23
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | $3.17B | $18.32 | — |
| BHC | Bausch Health Companies Inc. | $3.17B | $8.47 | — |
| BGM | BGM Group Ltd. | $3.09B | $8.13 | — |
| XERS | Xeris Biopharma Holdings, Inc. | $3.07B | $16.80 | — |
| TLX | Telix Pharmaceuticals Ltd | $3.01B | $8.85 | — |
News headlines (Yahoo Finance, 1h cache)
Is Return To Profit Altering The Investment Case For Legend Biotech (LEGN)?
2026-11-19 04:29 · Yahoo
Is Legend Biotech (LEGN) Reasonable After CARVYKTI Sales Growth?
2026-11-12 03:14 · Yahoo
Legend Biotech's Carvykti Positioned to Sustain Growth Into 2027, RBC Capital Markets Says
2026-11-11 16:43 · Yahoo
Legend Biotech (LEGN) Q3 2026 Earnings Call Transcript
2026-11-11 03:31 · Yahoo
Legend Biotech Corp (LEGN) Q3 2026 Earnings Call Highlights: CARVYKTI Sales Jump 36% as ...
2026-11-10 21:05 · Yahoo
LEGN Stock On Track For Worst Day Ever As Investors Focus On Decelerating US Demand For CARVYKTI Therapy
2026-11-10 20:11 · Yahoo
Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights
2026-11-10 12:00 · Yahoo
Legend Biotech to Showcase CARVYKTI® Leadership and Next-Generation Cell Therapy Innovation at ASH 2026
2026-11-04 14:00 · Yahoo
Legend Biotech Corporation Sponsored ADR (LEGN) Recently Broke Out Above the 200-Day Moving Average
2026-10-29 12:30 · Yahoo
Legend Biotech (LEGN) Stock Could Trade Below Its Sales Backdrop
2026-10-28 06:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.